Technology | January 19, 2010

New Suite of Tools Aids Cardiovascular Research

January 19, 2010 – A family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro was launched today by iWorks. The systems, software and components are used for a number of research applications, including measuring and analyzing blood pressure, electrocardiograms, blood flow and cardiac output, pressure-volume, sonomicrometry dimension and volume, isolated Langendorff and working heart models and isolated tissue studies.

iWorx LabScribe2 recording and analysis software provides a comprehensive set of preconfigured routines to simplify data interpretation and analysis. Specific software modules for cardiovascular research are available to analyze pressure signals, blood flow data, ECG recordings, ventricular pressure-volume loops and sonomicrometry dimension data. The software can display up to 128 channels of data simultaneously at sampling rates as high as 100,000 samples/second.

iWorx cardiovascular research solutions include complete tissue baths systems, blood flow systems, and myograph systems. A wide range of transducers, amplifiers, signal conditioners, multi-channel data recorders and accessories can be used for in situ experiments, isolated heart preparations and isolated tissue protocols.

For more information: www.iworx.com.


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now